Castle Biosciences (CSTL) stock forecast for 2026

The forecast has been updated: December 3, 2021 9:15


Castle Biosciences stock price online today

Analyst Target Price

87.5

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Castle Biosciences stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? Castle Biosciences stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $87.5 target price for Castle Biosciences stock stock.

Today 200 Day Moving Average is the resistance level (66.19 $).

50 Day Moving Average is the resistance level (59.16 $).




CSTL Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 53.32 49.44 55.71 11.26 %
Feb 58.62 55.50 63.71 12.88 %
Mar 56.90 51.56 60.72 15.09 %
Apr 60.01 55.89 62.78 10.97 %
May 60.85 54.71 66.81 18.11 %
Jun 53.61 52.03 56.76 8.33 %
Jul 57.36 51.09 62.26 17.93 %
Aug 59.21 55.64 65.34 14.84 %
Sep 61.53 58.08 64.71 10.25 %
Oct 66.52 60.28 73.32 17.78 %
Nov 66.15 61.98 68.46 9.47 %
Dec 70.32 65.00 77.21 15.81 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Castle Biosciences stock.


Castle Biosciences overview

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization

1 046 169 000 $

EBITDA

5 935 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

None

Dividend Yield

0

EPS

-1.239

Quarterly Earnings Growth YOY

-0.926

Quarterly Revenue Growth YOY

0.543

Trailing PE

-

Forward PE

-

EV To Revenue

10.26

EV To EBITDA

11562.57

52 Week High

107.69

52 Week Low

39.34

50 Day Moving Average

59.16

200 Day Moving Average

66.19

Shares Outstanding

25300300

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Castle Biosciences stock forecast for this year


Castle Biosciences stock forecast for Jan 2026.
Estimated Average Forecasted Castle Biosciences Price: 53.32. Positive monthly dynamics of the instrument is expected with 11.256% volatility is expected.

Pessimistic forecast: 49.44

Optimistic: 55.71


Castle Biosciences stock forecast for Feb 2026.
Estimated Average Forecasted Castle Biosciences Price: 58.62. Positive monthly dynamics of the instrument is expected with 12.882% volatility is expected.

Pessimistic forecast: 55.50

Optimistic: 63.71


Castle Biosciences stock forecast for Mar 2026.
Estimated Average Forecasted Castle Biosciences Price: 56.90. Negative monthly dynamics of the instrument is expected with 15.086% volatility is expected.

Pessimistic forecast: 51.56

Optimistic: 60.72


Castle Biosciences stock forecast for Apr 2026.
Estimated Average Forecasted Castle Biosciences Price: 60.01. Positive monthly dynamics of the instrument is expected with 10.973% volatility is expected.

Pessimistic forecast: 55.89

Optimistic: 62.78


Castle Biosciences stock forecast for May 2026.
Estimated Average Forecasted Castle Biosciences Price: 60.85. Positive monthly dynamics of the instrument is expected with 18.106% volatility is expected.

Pessimistic forecast: 54.71

Optimistic: 66.81


Castle Biosciences stock forecast for Jun 2026.
Estimated Average Forecasted Castle Biosciences Price: 53.61. Negative monthly dynamics of the instrument is expected with 8.330% volatility is expected.

Pessimistic forecast: 52.03

Optimistic: 56.76


Castle Biosciences stock forecast for Jul 2026.
Estimated Average Forecasted Castle Biosciences Price: 57.36. Positive monthly dynamics of the instrument is expected with 17.929% volatility is expected.

Pessimistic forecast: 51.09

Optimistic: 62.26


Castle Biosciences stock forecast for Aug 2026.
Estimated Average Forecasted Castle Biosciences Price: 59.21. Positive monthly dynamics of the instrument is expected with 14.842% volatility is expected.

Pessimistic forecast: 55.64

Optimistic: 65.34


Castle Biosciences stock forecast for Sep 2026.
Estimated Average Forecasted Castle Biosciences Price: 61.53. Positive monthly dynamics of the instrument is expected with 10.249% volatility is expected.

Pessimistic forecast: 58.08

Optimistic: 64.71


Castle Biosciences stock forecast for Oct 2026.
Estimated Average Forecasted Castle Biosciences Price: 66.52. Positive monthly dynamics of the instrument is expected with 17.783% volatility is expected.

Pessimistic forecast: 60.28

Optimistic: 73.32


Castle Biosciences stock forecast for Nov 2026.
Estimated Average Forecasted Castle Biosciences Price: 66.15. Negative monthly dynamics of the instrument is expected with 9.469% volatility is expected.

Pessimistic forecast: 61.98

Optimistic: 68.46


Castle Biosciences stock forecast for Dec 2026.
Estimated Average Forecasted Castle Biosciences Price: 70.32. Positive monthly dynamics of the instrument is expected with 15.811% volatility is expected.

Pessimistic forecast: 65.00

Optimistic: 77.21



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 130.27 (03.12.2021) 1.47 %
AbbVie Inc.
ABBV 118.85 (03.12.2021) 1.69 %
Aeterna Zentaris Inc.
AEZS 0.4 (03.12.2021) -7.21 %
Allakos Inc.
ALLK 74.02 (03.12.2021) -3.10 %
Allogene Therapeutics, Inc.
ALLO 17.62 (03.12.2021) -7.70 %
Amgen Inc.
AMGN 202.44 (03.12.2021) 0.63 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17.09 (03.12.2021) -5.11 %
Aurora Cannabis Inc.
ACB 5.82 (03.12.2021) -5.21 %
Becton Dickinson and Company
BDX 244.12 (03.12.2021) 0.90 %
Biogen Inc.
BIIB 223.92 (03.12.2021) -2.01 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 103.56 (03.12.2021) -5.24 %
BioNTech SE
BNTX 344.06 (03.12.2021) 3.17 %
bluebird bio, Inc.
BLUE 9.95 (03.12.2021) -6.40 %
Boston Scientific Corp.
BSX 39.46 (03.12.2021) -0.35 %
Bristol-Myers Squibb Company
BMY 56.32 (03.12.2021) 1.64 %
Canopy Growth Corp.
CGC 9.99 (03.12.2021) -3.57 %
Castle Biosciences, Inc.
CSTL 41.43 (03.12.2021) -1.17 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.91 (15.10.2021) -2.59 %
Eli Lilly and Company
LLY 245.58 (03.12.2021) -0.93 %
Emergent BioSolutions Inc.
EBS 41.89 (03.12.2021) -1.94 %
Exelixis, Inc.
EXEL 15.84 (03.12.2021) -3.88 %
G1 Therapeutics, Inc.
GTHX 10.65 (03.12.2021) -11.69 %
Gilead Sciences, Inc.
GILD 69.56 (03.12.2021) -0.16 %
GlaxoSmithKline plc
GSK 41.25 (03.12.2021) -0.53 %
GoodRx Holdings, Inc.
GDRX 38.42 (03.12.2021) -3.13 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 65.78 (03.12.2021) -1.28 %
Inovio Pharmaceuticals, Inc.
INO 6.17 (03.12.2021) -6.66 %
Johnson & Johnson
JNJ 159.38 (03.12.2021) 1.46 %
Medtronic plc.
MDT 106.87 (03.12.2021) -0.38 %
Merck & Co., Inc.
MRK 73.34 (03.12.2021) -0.74 %
Moderna, Inc.
MRNA 306.72 (03.12.2021) 1.73 %
Novartis AG
NVS 80 (03.12.2021) 0.06 %
Novavax, Inc.
NVAX 160.48 (03.12.2021) -0.92 %
ObsEva SA
OBSV 2.02 (03.12.2021) -4.27 %
OrganiGram Holdings Inc.
OGI 1.82 (03.12.2021) -6.67 %
Pfizer Inc.
PFE 54.27 (03.12.2021) 2.32 %
Regeneron Pharmaceuticals, Inc.
REGN 635.16 (03.12.2021) 0.18 %
Sanofi
SNY 47.07 (03.12.2021) -1.30 %
Schrodinger, Inc.
SDGR 36.33 (03.12.2021) -4.97 %
Senseonics Holdings, Inc.
SENS 2.69 (03.12.2021) -5.94 %
Sorrento Therapeutics, Inc.
SRNE 4.945 (03.12.2021) -10.25 %
Stryker Corp.
SYK 246.87 (03.12.2021) -0.21 %
Sundial Growers Inc.
SNDL 0.564 (03.12.2021) -4.73 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.05 (03.12.2021) -1.35 %
Thermo Fisher Scientific Inc.
TMO 636.11 (03.12.2021) 1.36 %
Tilray, Inc.
TLRY 8.95 (03.12.2021) -6.18 %
UnitedHealth Group, Inc.
UNH 449.32 (03.12.2021) 0.74 %
Veeva Systems Inc.
VEEV 249.49 (03.12.2021) -4.92 %
Zomedica Corp.
ZOM 0.33 (03.12.2021) -13.16 %
Zynerba Pharmaceuticals, Inc.
ZYNE 3.19 (03.12.2021) -4.49 %

Warning: include(include/reklama_bottom.php): failed to open stream: No such file or directory in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808 Warning: include(): Failed opening 'include/reklama_bottom.php' for inclusion (include_path='.:') in /home/virtwww/w_leoprophet-com_a7e4ac46/http/wp-content/themes/generatepress/forecast_stock_post_year.php on line 808

Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.